Nicola Black,Sophie Chung,Calvert Tisdale,Luz Sousa Fialho,Apinun Aramrattana,Sawitri Assanangkornchai,Alex Blaszczynski,Henrietta Bowden-Jones,Wim van den Brink,Adrian Brown,Qiana L. Brown,Linda B. Cottler,Maury Elsasser,Marica Ferri,Maria Florence,Ralitza Gueorguieva,Ryan Hampton,Suzie Hudson,Peter J. Kelly,Nicholas Lintzeris,Lynette Murphy,Abhijit Nadkarni,Joanne Neale,Daniel Rosen,Hans-Jürgen Rumpf,Brian Rush,Gabriel Segal,Gillian W. Shorter,Marta Torrens,Christopher Wait,Katherine Young,Michael Farrell

Abstract:Background: In 1990, the United States' Institute of Medicine promoted the principles of outcomes monitoring in the alcohol and other drugs treatment field to improve the evidence synthesis and quality of research. While various national outcome measures have been developed and employed, no global consensus on standard measurement has been agreed for addiction. It is thus timely to build an international consensus. Convened by the International Consortium for Health Outcomes Measurement (ICHOM), an international, multi-disciplinary working group reviewed the existing literature and reached consensus for a globally applicable minimum set of outcome measures for people who seek treatment for addiction. Methods: To this end, 26 addiction experts from 11 countries and 5 continents, including people with lived experience (n = 5; 19%), convened over 16 months (December 2018–March 2020) to develop recommendations for a minimum set of outcome measures. A structured, consensus-building, modified Delphi process was employed. Evidence-based proposals for the minimum set of measures were generated and discussed across eight videoconferences and in a subsequent structured online consultation. The resulting set was reviewed by 123 professionals and 34 people with lived experience internationally. Results: The final consensus-based recommendation includes alcohol, substance, and tobacco use disorders, as well as gambling and gaming disorders in people aged 12 years and older. Recommended outcome domains are frequency and quantity of addictive disorders, symptom burden, health-related quality of life, global functioning, psychosocial functioning, and overall physical and mental health and wellbeing. Standard case-mix (moderator) variables and measurement time points are also recommended. Conclusions: Use of consistent and meaningful outcome measurement facilitates carer–patient relations, shared decision-making, service improvement, benchmarking, and evidence synthesis for the evaluation of addiction treatment services and the dissemination of best practices. The consensus set of recommended outcomes is freely available for adoption in healthcare settings globally.

Standardizing terminology in addiction science: to achieve the impossible dream

Substance, not semantics, is the issue: comments on the proposed addiction criteria for DSM-V.

Addictive and Other Mental Disorders: a Call for a Standardized Definition of Dual Disorders

How can we conceptualize behavioural addiction without pathologizing common behaviours?

A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study

Issues in the definition and diagnosis of alcoholism: implications for a reformulation.

The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research

The trouble with alcohol abuse: what are we trying to measure, diagnose, count and prevent?

An International, Multidisciplinary Consensus Set of Patient-Centered Outcome Measures for Substance-Related and Addictive Disorders

Exclusion of the non-English-speaking world from the scientific literature: Recommendations for change for addiction journals and publishers

A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine

Addiction as a brain disease revised: why it still matters, and the need for consilience

Subtypes of substance dependence and abuse: implications for diagnostic classification and empirical research

Addiction theory matters-Why there is no dependence on caffeine or antidepressant medication

Breaking Barriers in the Genomics and Pharmacogenetics of Drug Addiction

Making alcohol and tobacco preventable deaths truly preventable! Addiction as a modifiable risk factor for alcohol and tobacco preventable mortality

Digital interventions targeting excessive substance use and substance use disorders: a comprehensive and systematic scoping review and bibliometric analysis

Revisiting Preaddiction

Social, scientific, and medical issues in the definition of alcohol and drug dependence

The biological, social and clinical bases of drug addiction: commentary and debate.

Nosological considerations in the diagnosis of substance use disorders.